Adrenal Cortex Neoplasms
"Adrenal Cortex Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the ADRENAL CORTEX.
Descriptor ID |
D000306
|
MeSH Number(s) |
C04.588.322.078.265 C19.053.098.265 C19.053.347.500 C19.344.078.265
|
Concept/Terms |
Adrenal Cortex Neoplasms- Adrenal Cortex Neoplasms
- Neoplasms, Adrenal Cortex
- Adrenal Cortex Neoplasm
- Neoplasm, Adrenal Cortex
Adrenocortical Cancer- Adrenocortical Cancer
- Adrenocortical Cancers
- Cancer, Adrenocortical
- Cancers, Adrenocortical
- Cancer of Adrenal Cortex
- Adrenal Cortex Cancers
- Cancer of the Adrenal Cortex
- Adrenal Cortex Cancer
- Cancer, Adrenal Cortex
- Cancers, Adrenal Cortex
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Cortex Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Cortex Neoplasms".
This graph shows the total number of publications written about "Adrenal Cortex Neoplasms" by people in this website by year, and whether "Adrenal Cortex Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 2 | 0 | 2 | 2008 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2017 | 2 | 0 | 2 | 2018 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2020 | 4 | 0 | 4 | 2021 | 2 | 0 | 2 | 2022 | 1 | 0 | 1 | 2023 | 4 | 0 | 4 | 2024 | 7 | 0 | 7 | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenal Cortex Neoplasms" by people in Profiles.
-
Schiavon A, Saba L, Evaristo C, Petiti J, Pignochino Y, Ferrero G, Giordano G, Tucciarello C, Puglisi S, Reimondo G, Terzolo M, Lo Iacono M. Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells. Biomed Pharmacother. 2025 Mar; 184:117917.
-
Subramanian C, McNamara K, Croslow SW, Tan Y, Hess D, Kiseljak-Vassiliades K, Wierman ME, Sweedler JV, Cohen MS. Novel repurposing of sulfasalazine for the treatment of adrenocortical carcinomas, probably through the SLC7A11/xCT-hsa-miR-92a-3p-OIP5-AS1 network pathway. Surgery. 2025 01; 177:108832.
-
Del Rivero J, Else T, Hallanger-Johnson J, Kiseljak-Vassiliades K, Raj N, Reidy-Lagunes D, Srinivas S, Gilbert J, Vaidya A, Aboujaoude E, Bancos I, Tito Fojo A. A review of mitotane in the management of adrenocortical cancer. Oncologist. 2024 Sep 06; 29(9):747-760.
-
Arakawa Y, Elloumi F, Varma S, Khandagale P, Jo U, Kumar S, Roper N, Reinhold WC, Robey RW, Takebe N, Gottesman MM, Thomas CJ, Boeva V, Berruti A, Abate A, Tamburello M, Sigala S, Hantel C, Weigand I, Wierman ME, Kiseljak-Vassiliades K, Del Rivero J, Pommier Y. A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples. Cancer Res Commun. 2024 09 01; 4(9):2384-2398.
-
Ziogas IA, Hills-Dunlap JL, Corkum KS, Cost NG, Gosain A, Roach JP. Current Management Strategies and Outcomes in Children With Adrenocortical Carcinoma. J Surg Res. 2024 Sep; 301:110-117.
-
Scatolini M, Grisanti S, Tomaiuolo P, Grosso E, Basile V, Cosentini D, Puglisi S, Lagan? M, Perotti P, Saba L, Rossini E, Palermo F, Sigala S, Volante M, Berruti A, Terzolo M. Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. Eur J Cancer. 2024 Jul; 205:114088.
-
Wierman ME. Mitotane: a friend or a foe before cabozantinib treatment in adrenocortical cancer? Lancet Oncol. 2024 May; 25(5):534-535.
-
Wierman ME, Vassiliades KK. ADRENOCORTICAL CARCINOMA: AN ORPHAN MALIGNANCY: FROM THE PATIENT TO THE BENCH AND BACK. Trans Am Clin Climatol Assoc. 2024; 134:113-122.
-
Schiavon A, Saba L, Catucci G, Petiti J, Puglisi S, Borin C, Reimondo G, Gilardi G, Giachino C, Terzolo M, Lo Iacono M. Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients' Management. Int J Mol Sci. 2023 Nov 24; 24(23).
-
McDonald HG, Sarvestani AL, Owen JW, Rueckert J, Wierman ME, Kiseljak-Vassiliades K, Pandalai PK, Ellis CS, Patel RA, Del Rivero J, Hernandez JM, Cavnar MJ. Response of adrenocortical carcinoma liver metastases to hepatic artery infusion floxuridine. HPB (Oxford). 2023 11; 25(11):1446-1449.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|